Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Glycosphingolipid Metabolism to Treat Kidney Disease.
Nephron. 2016;134(1):37-42. doi: 10.1159/000444926. Epub 2016 Mar 9.
Nephron. 2016.
PMID: 26954668
Free PMC article.
Review.
The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases.
Shayman JA, Larsen SD.
Shayman JA, et al.
J Lipid Res. 2014 Jul;55(7):1215-25. doi: 10.1194/jlr.R047167. Epub 2014 Feb 17.
J Lipid Res. 2014.
PMID: 24534703
Free PMC article.
Review.
Item in Clipboard
Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease.
Shayman JA.
Shayman JA.
Semin Nephrol. 2018 Mar;38(2):183-192. doi: 10.1016/j.semnephrol.2018.01.007.
Semin Nephrol. 2018.
PMID: 29602400
Free PMC article.
Review.
Item in Clipboard
Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.
Glukhova A, Hinkovska-Galcheva V, Kelly R, Abe A, Shayman JA, Tesmer JJ.
Glukhova A, et al.
Nat Commun. 2015 Mar 2;6:6250. doi: 10.1038/ncomms7250.
Nat Commun. 2015.
PMID: 25727495
Free PMC article.
Item in Clipboard
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury.
Dupre TV, Doll MA, Shah PP, Sharp CN, Siow D, Megyesi J, Shayman J, Bielawska A, Bielawski J, Beverly LJ, Hernandez-Corbacho M, Clarke CJ, Snider AJ, Schnellmann RG, Obeid LM, Hannun YA, Siskind LJ.
Dupre TV, et al.
J Lipid Res. 2017 Jul;58(7):1439-1452. doi: 10.1194/jlr.M076745. Epub 2017 May 10.
J Lipid Res. 2017.
PMID: 28490444
Free PMC article.
Item in Clipboard
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3.
Wilson MW, Shu L, Hinkovska-Galcheva V, Jin Y, Rajeswaran W, Abe A, Zhao T, Luo R, Wang L, Wen B, Liou B, Fannin V, Sun D, Sun Y, Shayman JA, Larsen SD.
Wilson MW, et al.
ACS Chem Neurosci. 2020 Oct 21;11(20):3464-3473. doi: 10.1021/acschemneuro.0c00558. Epub 2020 Oct 9.
ACS Chem Neurosci. 2020.
PMID: 33035424
Free PMC article.
Item in Clipboard
Cite
Cite